Lu AF28996 in Participants With Parkinson's Disease (PD)

NCT04291859 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Lu AF28996

Sponsor

H. Lundbeck A/S